N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: A Valuable Endogenous Anti-Fibrotic Peptide for Combating Kidney Fibrosis in Diabetes
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2014.00070
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 14, 2014
Authors
Publisher
Frontiers Media SA